Moderna Inc. buy Royal Bank of Canada
Start price
23.02.24
/
50%
€89.00
Target price
23.02.25
€115.45
Performance (%)
-62.03%
End price
24.02.25
€33.79
Summary
This prediction ended on 24.02.25 with a price of €33.79. Massive losses of -62.03% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 3.339% | 3.339% | 110.828% |
| iShares Core DAX® | 0.411% | 8.821% | 12.264% |
| iShares Nasdaq 100 | 3.678% | 10.820% | 44.017% |
| iShares Nikkei 225® | 2.701% | 15.247% | 48.041% |
| iShares S&P 500 | 2.445% | 7.933% | 32.998% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $125.00 price target on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten